These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6306672)

  • 21. Genetic influences on the immunologic pathogenesis of encephalomyocarditis (EMC) virus-induced diabetes mellitus.
    Huber SA; Babu PG; Craighead JE
    Diabetes; 1985 Nov; 34(11):1186-90. PubMed ID: 2995182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic differences in susceptibility of pancreatic beta cells to virus-induced diabetes mellitus.
    Yoon JW; Lesniak MA; Fussganger R; Notkins AL
    Nature; 1976 Nov; 264(5582):178-80. PubMed ID: 186716
    [No Abstract]   [Full Text] [Related]  

  • 23. Relationship of interferon-inducing particle phenotype to encephalomyocarditis virus-induced diabetes mellitus.
    Cohen SH; Bolton V; Jordan GW
    Infect Immun; 1983 Nov; 42(2):605-11. PubMed ID: 6315581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trypanosoma brucei rhodesiense infection in mice prevents virus-induced diabetes: possible role of interferon and immunological mechanisms.
    Gould CL; De Gee AL; Mansfield JM; Sonnenfeld G
    J Interferon Res; 1986 Oct; 6(5):499-506. PubMed ID: 2433362
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus.
    Bigley NJ; Blay RA; Smith RA
    Diabetes; 1987 Dec; 36(12):1408-13. PubMed ID: 2824259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modification of encephalomyocarditis virus-induced diabetes in mice by antiviral agents.
    Powers RD; Dotson WM; Hayden FG
    Antiviral Res; 1983 Sep; 3(3):151-9. PubMed ID: 6197026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of antigenic differences between the diabetogenic and non-diabetogenic variants of encephalomyocarditis virus using monoclonal antibodies.
    Yoon JW; Ko W; Bae YS; Pak CY; Amano K; Eun HM; Kim MK
    J Gen Virol; 1988 May; 69 ( Pt 5)():1085-90. PubMed ID: 2836552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Encephalomyocarditis (EMC) virus-induced diabetes mellitus prevented by Corynebacterium parvum in mice.
    Kounoue E; Nagafuchi S; Nakamura M; Nakano S; Koga T; Nakayama M; Mituyama M; Niho Y; Takaki R
    Experientia; 1987 Apr; 43(4):430-1. PubMed ID: 3032672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral activity of an extract of Brucella abortus: induction of interferon and immunopotentiation of host resistance.
    Kern ER; Glasgow LA; Overall JC
    Proc Soc Exp Biol Med; 1976 Jul; 152(3):372-6. PubMed ID: 181760
    [No Abstract]   [Full Text] [Related]  

  • 30. Virus-induced diabetes mellitus. IV. Genetic and environmental factors influencing the development of diabetes after infection with the M variant of encephalomyocarditis virus.
    Ross ME; Onodera T; Brown KS; Notkins AL
    Diabetes; 1976 Mar; 25(3):190-7. PubMed ID: 176076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of diabetes by cumulative environmental insults from viruses and chemicals.
    Toniolo A; Onodera T; Yoon JW; Notkins AL
    Nature; 1980 Nov; 288(5789):383-5. PubMed ID: 6253833
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of steroid hormones on virus-induced diabetes mellitus.
    Giron DJ; Patterson RR
    Infect Immun; 1982 Aug; 37(2):820-2. PubMed ID: 6288572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cytokines produced early in picornavirus infection reflect resistance or susceptibility to disease.
    Curiel RE; Mason KM; Dryden TD; Maurer MJ; Bigley NJ
    J Interferon Cytokine Res; 1998 Aug; 18(8):587-96. PubMed ID: 9726440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-induced diabetes mellitus. VI. Genetically determined host differences in the replicating of encephalomyocarditis virus in pancreatic beta cells.
    Yoon JW; Notkins AL
    J Exp Med; 1976 May; 143(5):1170-85. PubMed ID: 177713
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ameliorating effect of IFN-beta and anti-IFN-beta on coxsackievirus B3-induced myocarditis in mice.
    Lutton CW; Gauntt CJ
    J Interferon Res; 1985; 5(1):137-46. PubMed ID: 2985716
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Protective action of double-stranded complexes--interferon inducers in encephalomyocarditis in mice].
    Nosik NN; Lavrukhina LA; Ershov FI
    Biull Eksp Biol Med; 1984 Apr; 97(4):446-8. PubMed ID: 6326886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered pathogenesis in encephalomyocarditis virus (D variant)-infected diabetes-susceptible and resistant strains of mice.
    Gaines KL; Kayes SG; Wilson GL
    Diabetologia; 1986 May; 29(5):313-20. PubMed ID: 3013707
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute infection of encephalomyocarditis (EMC) virus in Syrian hamsters.
    Sugawara Y; Hirasawa K; Takeda M; Han JS; Doi K
    J Vet Med Sci; 1991 Jun; 53(3):463-8. PubMed ID: 1653039
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for a single locus controlling susceptibility to virus-induced diabetes mellitus.
    Onodera T; Yoon JW; Brown KS; Notkina AL
    Nature; 1978 Aug; 274(5672):693-6. PubMed ID: 209341
    [No Abstract]   [Full Text] [Related]  

  • 40. Perspectives on the role of viruses in insulin-dependent diabetes.
    Yoon JW; Ray UR
    Diabetes Care; 1985; 8 Suppl 1():39-44. PubMed ID: 2996865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.